I was two years old when I was diagnosed with sickle cell HbSC disease. By age 10, I had already survived four surgeries. I don’t remember a life without this disease — without the hospitalizations, ...

In 2022, the team at Cortical Labs taught 800,000 brain cells in a petri dish connected to a computer how to play the 1970s game Pong. Now, years later, the same team is leveling up as they claim ...

A pair of new studies have provided fresh evidence in the long-running scientific debate—and the result could be game-changing for treating diseases like Alzheimer’s and dementia. For decades ...

Stanford researchers have combined two microscopy techniques to create a one-of-a-kind instrument that can show cell structures interacting in real time at an unprecedented 120-nanometer ...

Add Popular Science (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results.

Scientists have built a massive cellular atlas showing how aging reshapes the body across 21 organs. Studying nearly 7 million cells, they found that aging starts earlier than expected and unfolds in ...

In 2022, Australian biotech startup Cortical Labs made a big splash after announcing that it had taught “mini-brains” consisting of 800,000 to one million living human brain cells in a petri dish how ...

A clump of human brain cells can play the classic computer game Doom. While its performance is not up to par with humans, experts say it brings biological computers a step closer to useful real-world ...

I went to federal prison for contempt of Congress. My detractors say I acted above the law. My supporters say I’m the poster child for a weaponized justice system. I won’t relitigate that here. What ...

Scientists in China have unveiled a breakthrough way to mass-produce powerful cancer-fighting immune cells in the lab. By engineering early-stage stem cells from cord blood—rather than trying to ...

Let’s say it’s 2036, and scientists are working on a new class of drugs. These medications are mirror-image versions of the molecules your body uses to fight disease. Their big advantage is that ...

CD7 is an attractive target for chimeric antigen receptor (CAR) T-cell therapy in relapsed or refractory T-cell acute lymphoblastic leukemia (ALL). Supportive results of first-in-human studies of base ...